daptomycin - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
PFIZER DAPTOMYCIN daptomycin 350 mg powder for injection vial
AUST R: 373705
Active ingredients:
daptomycin

Dosage form:
Inhalation, powder for

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

From
08 Nov 2024
to
30 May 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
Alternative generic products are available.

PFIZER DAPTOMYCIN daptomycin 500 mg powder for injection vial
AUST R: 373704
Active ingredients:
daptomycin

Dosage form:
Injection, powder for

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

From
13 Feb 2025
to
30 May 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Unexpected increase in demand due to other sponsors unable to supply

Management action:
The sponsor is working to expedite the next shipment. Alternative generic products are available.

DAPTOMYCIN DR.REDDY'S daptomycin 500 mg powder for injection vial
AUST R: 337791
Active ingredients:
daptomycin

Dosage form:
Injection, powder for

Sponsor:
Dr Reddys Laboratories Australia Pty Ltd

Phone:
0427306107

From
04 Jan 2024
to
31 Dec 2024

Shortage status:
Resolved

Availability:
Available

Reason:
Manufacturing

DAPTOMYCIN ACCORD daptomycin 500 mg powder for injection vial
AUST R: 315393
Active ingredients:
daptomycin

Dosage form:
Injection, powder for

Sponsor:
Accord Healthcare Pty Ltd

Phone:
1800 222 673

Deletion from market:
08 Oct 2024

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products are available.